<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Access Maced J Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Open Access Maced J Med Sci</journal-id><journal-title-group><journal-title>Open Access Macedonian Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="epub">1857-9655</issn><publisher><publisher-name>Republic of Macedonia</publisher-name><publisher-loc>ID Design 2012/DOOEL Skopje</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31949516</article-id><article-id pub-id-type="pmc">6953920</article-id><article-id pub-id-type="publisher-id">OAMJMS-7-3201</article-id><article-id pub-id-type="doi">10.3889/oamjms.2019.558</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Science</subject></subj-group></article-categories><title-group><article-title>Prevalence and Risk Factors for Hyponatremia in Preterm Infants</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hao</surname><given-names>Tran Kiem</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1">Pediatric Center, Hue Central Hospital, Hue, Vietnam</aff><author-notes><corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Tran Kiem Hao. Pediatric Center, Hue Central Hospital, Hue, Vietnam. Email: <email xlink:href="haotrankiem@yahoo.com">haotrankiem@yahoo.com</email></corresp></author-notes><pub-date pub-type="collection"><day>15</day><month>10</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>10</day><month>10</month><year>2019</year></pub-date><volume>7</volume><issue>19</issue><fpage>3201</fpage><lpage>3204</lpage><history><date date-type="received"><day>16</day><month>4</month><year>2019</year></date><date date-type="rev-recd"><day>04</day><month>9</month><year>2019</year></date><date date-type="accepted"><day>05</day><month>9</month><year>2019</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2019 Tran Kiem Hao, Nguyen Huu Son.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/CC BY-NC/4.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)</license-p></license></permissions><abstract><sec id="st1"><title>BACKGROUND:</title><p>Hyponatremia is the result of a negative sodium balance caused by inadequate salt intake or excessive salt loss due to immature renal or intestinal function in preterm infants.</p></sec><sec id="st2"><title>AIM:</title><p>The aim of our study was to define the incidence of and factors affecting its development in preterm newborns.</p></sec><sec id="st3"><title>METHODS:</title><p>This was a retrospective cohort analysis of 126 preterm infants born before 36 weeks of gestation between June 2016 and July 2018 at Neonatal Intensive Care Unit of Hue Central Hospital, Vietnam. Hyponatremia was defined as a sodium level &#x02264; 132 mEq/L or 133-135 mEq/L with oral sodium supplementation. We used the serum sodium level to define hyponatremia.</p></sec><sec id="st4"><title>RESULTS:</title><p>There were 37 infants who had hyponatremia, accounting for 29.4% of the infants enrolled in the study. Alower gestational age, the presence of respiratory distress syndrome, the use of furosemide, and feeding with breast milk were significant risk factors for hyponatremia in preterm newborns.</p></sec><sec id="st5"><title>CONCLUSION:</title><p>Hyponatremia occurred at a relatively high frequency. This result exemplifies the importance of serum sodium monitoring and supplementation for the correction of hyponatremia.</p></sec></abstract><kwd-group><kwd>Hyponatremia</kwd><kwd>Preterm newborns</kwd><kwd>Risk factors</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Sodium, an element essential to growth, is contained in bone, cartilage and connective tissue and is indispensable for the development and operation of the central nervous system. Mild hyponatraemia is common in preterm babies and is not known to cause significant adverse effects [<xref rid="ref1" ref-type="bibr">1</xref>]. On the contrary, extreme hyponatraemia is rarely seen and increases the risk of neurodisability [<xref rid="ref2" ref-type="bibr">2</xref>], [<xref rid="ref3" ref-type="bibr">3</xref>]. Many factors predispose preterm babies to hyponatraemia: impaired reabsorption of sodium at both proximal and distal tubules [<xref rid="ref4" ref-type="bibr">4</xref>], inadequate salt provision, <italic>e.g</italic>.with donor breast milk [<xref rid="ref5" ref-type="bibr">5</xref>], immaturity of endocrine mechanisms of water and sodium homeostasis [<xref rid="ref6" ref-type="bibr">6</xref>]. Hypoxia, medications and respiratory distress can also aggravate hyponatremia associated with kidney tubular damage. However, few studies have addressed the incidence of and risk factors for hyponatremia in preterm newborns is achieved.</p><p>In this study, we aimed to define the incidence of and factors affecting its development in preterm newborns.</p></sec><sec sec-type="material|methods" id="sec1-2"><title>Material and Methods</title><p>Our retrospective cohort was composed of 126 preterm infants born before 37 weeks of gestation and admitted to the Neonatal Intensive Care Unit of Hue Central Hospital, Vietnam between June 2016 and July 2018. The data were collected via a retrospective chart review. The collected data included the infants&#x02019; perinatal histories, clinical characteristics (including hyponatremia). This study was approved by the Hue Central Hospital institutional review board. Informed consent was waived by the board.</p><p>Hyponatremia was defined as a sodium level &#x02264; 132 mEq/L or between 133 and 135 mEq/L with oral sodium supplementation [<xref rid="ref7" ref-type="bibr">7</xref>]. According to our nutritional policy, total parenteral nutrition was started from birth and also protein and lipid supplementation was started at day 1. Sodium supplementation was started after diuresis begins according to the capillary or serum sodium level. If there is a hyponatremia, we routinely checked sodium level every 1-3 days to assess whether hyponatremia is relieved. The duration of hyponatremia was defined as the length of time when the sodium level was &#x02264; 132 mEq/L. We used the serum sodium level to define hyponatremia.</p><p>All the numerical data are expressed as the means&#x000b1;standard deviation. The <italic>t</italic>-test or the Mann-Whitney test was used for continuous variables. The chi-square test or Fisher&#x02019;s exact test was used for the analysis of categorical variables.</p><p>To evaluate the risk factors for hyponatremia, we compared the perinatal factors of the hyponatremia and non-hyponatremia groups during the study period. Amultiple logistic regression using a stepwise selection was employed, and we included significant variables (those with <italic>P</italic> values below 0.05) in a univariate analysis. The statistical analysis was conducted using SPSS Statistics version 20.</p></sec><sec sec-type="results" id="sec1-3"><title>Results</title><sec id="sec2-1"><title>Patient characteristics</title><p>Atotal of 126 infants born at 24 through 36 weeks of gestation were included in this retrospective cohort study. More than one-half of the entire cohort was male (59.5%), and 81% of the births were a singleton.</p><p>There were 37 infants who had hyponatremia, accounting for 29.4% of the infants enrolled in the study. The mean gestational age of the hyponatremia group was 29.1 &#x000b1; 3.2 weeks (minimum-maximum; 23-33 weeks), and their mean birth weight was 973.7 &#x000b1; 315.9 g (820-2,250 g). The mean onset of hyponatremia was 3.4 &#x000b1; 1.5 days after birth (1-12 days), and the mean duration of hyponatremia was 3.23 &#x000b1; 2.18 days (1-6 days). Of the 37 infants with hyponatremia, 13 (35.1%) experienced a hyponatremia duration of at least 4 days. There were no infants with serious neurologic complications associated with hyponatremia.</p></sec><sec id="sec2-2"><title>Risk factors for hyponatremia</title><p>The hyponatremia group had a lower gestational age and a lower birth weight than did the non-hyponatremia group (<italic>P</italic> &#x0003c; 0.01). Premature rupture of the membranes occurring more than 18 hr before the delivery, the use of prenatal antibiotics, respiratory distress syndrome, patent ductus arteriosus requiring medical, postnatal culture-proven sepsis, and the use of postnatal antibiotics or furosemide within two weeks after birth occurred significantly more frequently in the hyponatremia group (<italic>P</italic> &#x0003c; 0.05). Feeding with breast milk was more common in the hyponatremia group (<italic>P</italic> &#x0003c; 0.05) (<xref rid="T1" ref-type="table">Table 1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1:</label><caption><p>Univariate analyses of perinatal and neonatal factors between hyponatremia group and non-hyponatremia groups</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">parameters</th><th align="center" rowspan="1" colspan="1">Non- hyponatremia group (n = 89)</th><th align="center" rowspan="1" colspan="1">Hyponatremia group (n = 37)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GA at birth (weeks), &#x000b1; SD</td><td align="center" rowspan="1" colspan="1">32.1 &#x000b1; 2.7</td><td align="center" rowspan="1" colspan="1">29.3 &#x000b1; 3.4</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Birth weight (g), &#x000b1; SD</td><td align="center" rowspan="1" colspan="1">1,550.2 &#x000b1; 439.3</td><td align="center" rowspan="1" colspan="1">1001.2 &#x000b1; 343.6</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">M:F ratio</td><td align="center" rowspan="1" colspan="1">1: 1.12</td><td align="center" rowspan="1" colspan="1">1: 1.08</td><td align="center" rowspan="1" colspan="1">0.65</td></tr><tr><td align="left" rowspan="1" colspan="1">5 min AS &#x0003c; 7, No. (%)</td><td align="center" rowspan="1" colspan="1">28 (31.4)</td><td align="center" rowspan="1" colspan="1">18 (48.6)</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">SGA, No. (%)</td><td align="center" rowspan="1" colspan="1">24 (26.7)</td><td align="center" rowspan="1" colspan="1">10 (27.0)</td><td align="center" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1">Oligohydramnious, No. (%)</td><td align="center" rowspan="1" colspan="1">11 (12.4)</td><td align="center" rowspan="1" colspan="1">6 (16.2)</td><td align="center" rowspan="1" colspan="1">0.58</td></tr><tr><td align="left" rowspan="1" colspan="1">Maternal hypertensive disorders, No. (%)</td><td align="center" rowspan="1" colspan="1">21 (23.6)</td><td align="center" rowspan="1" colspan="1">6 (16.2)</td><td align="center" rowspan="1" colspan="1">0.29</td></tr><tr><td align="left" rowspan="1" colspan="1">GDM, No. (%)</td><td align="center" rowspan="1" colspan="1">13 (14.6)</td><td align="center" rowspan="1" colspan="1">4 (10.8)</td><td align="center" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" rowspan="1" colspan="1">PROM &#x0003e; 18 hr, No. (%)</td><td align="center" rowspan="1" colspan="1">26 (29.2)</td><td align="center" rowspan="1" colspan="1">19 (51.3)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Prenatal antibiotics, No. (%)</td><td align="center" rowspan="1" colspan="1">32 (35.9)</td><td align="center" rowspan="1" colspan="1">21 (56.7)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Prenatal steroid, No. (%)</td><td align="center" rowspan="1" colspan="1">69 (77.5)</td><td align="center" rowspan="1" colspan="1">27 (73.0)</td><td align="center" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" rowspan="1" colspan="1">RDS, No. (%)</td><td align="center" rowspan="1" colspan="1">11 (12.3)</td><td align="center" rowspan="1" colspan="1">18 (48.6)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">PDA, No. (%)</td><td align="center" rowspan="1" colspan="1">34 (38.2)</td><td align="center" rowspan="1" colspan="1">29 (78.4)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Sepsis, No. (%)</td><td align="center" rowspan="1" colspan="1">8 (9.0)</td><td align="center" rowspan="1" colspan="1">9 (24.3)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">IVH &#x02265; Gr3, No. (%)</td><td align="center" rowspan="1" colspan="1">5 (5.6)</td><td align="center" rowspan="1" colspan="1">5 (13.5)</td><td align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">Antibiotics use, No. (%)</td><td align="center" rowspan="1" colspan="1">59 (66.3)</td><td align="center" rowspan="1" colspan="1">34 (91.9)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">BM feeding, No. (%)</td><td align="center" rowspan="1" colspan="1">29 (32.6)</td><td align="center" rowspan="1" colspan="1">24 (64.9)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Metabolic acidosis, No. (%)</td><td align="center" rowspan="1" colspan="1">11 (12.4)</td><td align="center" rowspan="1" colspan="1">3 (8.1)</td><td align="center" rowspan="1" colspan="1">0.53</td></tr><tr><td align="left" rowspan="1" colspan="1">Furosemide use, No. (%)</td><td align="center" rowspan="1" colspan="1">11 (12.4)</td><td align="center" rowspan="1" colspan="1">19 (51.4)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr></tbody></table><table-wrap-foot><fn id="t112n1"><p>GA, gesational age; SD, sandard deviation; M: F, male: female; AS, apgar score; SGA, small for gesational age; GDM, gesational diabetes mellitus; PROM, premature rupture of membrane; RDS, respiratory distress syndrome; PDA, persistent ductus arteriosus; IVH, intraventricular hemorrhage; Gr, grade by Volpe; BM, breast milk.</p></fn></table-wrap-foot></table-wrap><p>According to the multiple logistic regression analysis, a shorter gestation, a shorter duration of parenteral nutrition, the presence of respiratory distress syndrome, the use of furosemide, and feeding with breast milk were independently associated with the development of hyponatremia (<xref rid="T2" ref-type="table">Table 2</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Multivariate logistic regression analysis of risk factors of hyponatremia</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="3" colspan="1">variables</th><th align="center" rowspan="3" colspan="1">Odds ratio</th><th align="center" rowspan="3" colspan="1"><italic>P</italic> value</th><th align="center" colspan="2" rowspan="1">95% CI for estimate (OR)</th></tr><tr><th align="center" colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Lower</th><th align="center" rowspan="1" colspan="1">Upper</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GA (per week)</td><td align="center" rowspan="1" colspan="1">0.514</td><td align="center" rowspan="1" colspan="1">0.000</td><td align="center" rowspan="1" colspan="1">0.318</td><td align="center" rowspan="1" colspan="1">0.892</td></tr><tr><td align="left" rowspan="1" colspan="1">RDS</td><td align="center" rowspan="1" colspan="1">2.925</td><td align="center" rowspan="1" colspan="1">0.032</td><td align="center" rowspan="1" colspan="1">1.431</td><td align="center" rowspan="1" colspan="1">5.410</td></tr><tr><td align="left" rowspan="1" colspan="1">Furosemide use</td><td align="center" rowspan="1" colspan="1">3.081</td><td align="center" rowspan="1" colspan="1">0.009</td><td align="center" rowspan="1" colspan="1">2.043</td><td align="center" rowspan="1" colspan="1">5.804</td></tr><tr><td align="left" rowspan="1" colspan="1">BM feeding</td><td align="center" rowspan="1" colspan="1">2.416</td><td align="center" rowspan="1" colspan="1">0.044</td><td align="center" rowspan="1" colspan="1">1.522</td><td align="center" rowspan="1" colspan="1">4.394</td></tr></tbody></table><table-wrap-foot><fn><p>GA, gestational age; RDS, respiratory distress syndrome; BM, breast milk.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>During intrauterine life, the foetus lives in a warm, watery environment where it receives a constant supply of water and electrolytes from the mother. On the contrary, following birth, the neonate must adapt to a relatively cold, dry environment with much wider fluctuations than those experienced in the uterus [<xref rid="ref8" ref-type="bibr">8</xref>], [<xref rid="ref9" ref-type="bibr">9</xref>]. Variations in the hydro-electrolytic balance in the preterm neonate of very low weight are extreme due to the immaturity of the different organs. The immature kidney in particular leads to high toxicity caused by fluids: in excess when the supply of water is abundant and scanty when the supply of water is insufficient [<xref rid="ref10" ref-type="bibr">10</xref>]. An abundant supply of fluids is the cause of generalized oedemas and insufficient lung activity brought about by the increase in interstitial liquid directly or indirectly through maintenance of a patent Botallo duct [<xref rid="ref11" ref-type="bibr">11</xref>]. On the contrary, the insufficient administration of fluids may lead to hypovolemia, hyperosmolarity, metabolic anomalies and kidney insufficiency [<xref rid="ref12" ref-type="bibr">12</xref>]. Since the concentration of sodium in the serum is the main indicator of the water balance in the preterm infant, this group of patients presents a particular frequency of hyponatremia and hypernatremia [<xref rid="ref13" ref-type="bibr">13</xref>]. Recently, serious sequels associated with hyponatremia and variations in sodium concentration in preterm infants have been reported [<xref rid="ref13" ref-type="bibr">13</xref>], [<xref rid="ref14" ref-type="bibr">14</xref>]. Hyponatremia is most frequently caused by an excessive supply of water rather than by a reduced sodium intake, while hypernatremia is most frequently secondary to a reduced supply of water or increased losses of water rather than by a excessive supply of sodium [<xref rid="ref15" ref-type="bibr">15</xref>]. The questions and controversies in neonatology concern the supply of liquids in the first days of life and the amount of the sodium supplement.</p><p>In our study, 29.4% of preterm infants born before 36 weeks of gestation were affected by hyponatremia. Despite the relatively small sample size and limitation of a retrospective study, this is, to our knowledge, the first description of the incidence of hyponatremia in Vietnam. The significant risk factors for hyponatremia were a lower gestational age at birth, the presence of respiratory distress syndrome, furosemide use, and feeding with breast milk. Preterm neonates are at high risk for the development of hyponatremia because of (1) lower glomerular filtration rate, (2) reduced proximal tubular reabsorption of sodium, and (3) increased arginine vasopressin levels in response to illness [<xref rid="ref16" ref-type="bibr">16</xref>], [<xref rid="ref17" ref-type="bibr">17</xref>].</p><p>Some of the suggested pathophysiological causes of hyponatremia in premature babies are inadequate sodium intake and increased natriuresis, which can cause increased vasopressin. Our risk factor analysis supports these pathophysiological factors as causes of hyponatremia. In preterm infants, the immaturity of the proximal renal tubule can cause the decreased reabsorption of sodium. Numerous factors affecting the proximal tubule can aggravate hyponatremia, including hypoxia, respiratory distress, and the administration of drugs with tubular toxicity. Our study showed that the infants&#x02019; gestational age at birth and birth weight tended to be lower in the hyponatremia group and that respiratory distress syndrome was a significant risk factor for hyponatremia. Another significant risk factor was furosemide, a well-known diuretic that affects kidney tubules, causing massive natriuresis. Regarding inadequate sodium supplementation, feeding with breast milk were significant risk factors.</p><p>In the present study, the incidence of hyponatremia was as high as 29.4%. It will, therefore, be of great importance to clarify the clinical consequences of a low serum sodium level in premature babies. Some preliminary data have already indicated that neonatal sodium deficiency may have unfavorable consequences for later cognitive functions [<xref rid="ref14" ref-type="bibr">14</xref>], [<xref rid="ref18" ref-type="bibr">18</xref>]. Furthermore, hyponatremia has been documented to be a risk factor for cerebral palsy in extremely premature babies [<xref rid="ref19" ref-type="bibr">19</xref>].</p><p>In preterm infants, increased natriuresis due to renal tubular immaturity can lead to protracted volume contraction, which can stimulate aldosterone and arginine vasopressin (AVP) release, allowing further water retention and the progression of hyponatremia [<xref rid="ref20" ref-type="bibr">20</xref>], [<xref rid="ref21" ref-type="bibr">21</xref>], [<xref rid="ref22" ref-type="bibr">22</xref>]. The elevation of plasma AVP levels in bronchopulmonary dysplasia (BPD) infants both during the fourth week of life and as a chronic condition has also been reported [<xref rid="ref23" ref-type="bibr">23</xref>], [<xref rid="ref24" ref-type="bibr">24</xref>]. Although an impaired renal response to AVP in hyponatremic patients prevents the further worsening of hyponatremia [<xref rid="ref20" ref-type="bibr">20</xref>], elevated AVP levels in BPD patients can cause pulmonary fluid to accumulate, increasing pulmonary edema; therefore, hyponatremia may be a significant risk factor for BPD.</p><p>Postnatal growth retardation related to hyponatremia has also been reported [<xref rid="ref25" ref-type="bibr">25</xref>]. Sodium is a significant growth factor that stimulates cell proliferation and plays a significant role in protein turnover [<xref rid="ref26" ref-type="bibr">26</xref>]. NaCl deprivation inhibits growth, which is manifested in reductions in body weight, brain weight, body length, muscle and brain protein and RNAcontent, and brain lipid content (compared with controls). Subsequent NaCl supplementation restores the growth velocity; however, it does not induce catch-up growth [<xref rid="ref26" ref-type="bibr">26</xref>].</p><p>What does this mean for the practicing clinician? Neonatologists should make every effort to keep serum sodium concentrations in the normal range. Hyponatremia in preterm infants is an iatrogenic complication that should be preventable, because newborns start out life with normal serum sodium concentrations. One practice that needs to be reconsidered how parenteral fluids are being prescribed to the preterm neonate. Current recommendations are to prescribe 5% dextrose in water, only adding sodium after weight loss has been achieved [<xref rid="ref27" ref-type="bibr">27</xref>]. The reason for this recommendation is the concern that sodium supplementation in the immediate postnatal period will lead to extracellular volume expansion with the development of hypernatremia, worsening respiratory distress, necrotizing enterocolitis, and patent ductus arteriosus [<xref rid="ref28" ref-type="bibr">28</xref>], [<xref rid="ref29" ref-type="bibr">29</xref>].</p><p>In summary, hyponatremia occurred at a relatively high frequency. This result exemplifies the importance of serum sodium monitoring and supplementation for the correction of hyponatremia, especially if the hyponatremia persists for long periods despite a lack of acute symptoms. Nonetheless, as this was a retrospective study, hyponatremia might be only a marker of disease severity rather than an etiologic factor. Thus, further large cohort studies are needed in this area.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors are grateful to physicians, administrative staff at Neonatal Intensive Care Unit of Hue Central Hospital for allowing us to undertake this research.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Funding:</bold> This research did not receive any financial support</p></fn><fn fn-type="other"><p><bold>Competing Interests:</bold> The authors have declared that no competing interests exist</p></fn></fn-group><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modi</surname><given-names>N</given-names></name></person-group><article-title>Hyponatraemia in the newborn</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>1998</year><volume>78</volume><issue>2</issue><fpage>F81</fpage><lpage>4</lpage><comment>https://doi.org/10.1136/fn.78.2.F81 PMid:9577274 PMCid:PMC1720751</comment><pub-id pub-id-type="pmid">9577274</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laubenberger</surname><given-names>J</given-names></name><name><surname>Schneider</surname><given-names>B</given-names></name><name><surname>Ansorge</surname><given-names>O</given-names></name><name><surname>Gotz</surname><given-names>F</given-names></name><name><surname>Haussinger</surname><given-names>D</given-names></name><name><surname>Volk</surname><given-names>B</given-names></name><name><surname>Langer</surname><given-names>M</given-names></name></person-group><article-title>Central pontine myelinolysis:clinical presentation and radiologic findings</article-title><source>Eur Radiol</source><year>1996</year><volume>6</volume><issue>2</issue><fpage>177</fpage><lpage>83</lpage><comment>https://doi.org/10.1007/BF00181139 PMid:8797975</comment><pub-id pub-id-type="pmid">8797975</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterns</surname><given-names>RH</given-names></name><name><surname>Cappuccio</surname><given-names>JD</given-names></name><name><surname>Silver</surname><given-names>SM</given-names></name><name><surname>Cohen</surname><given-names>EP</given-names></name></person-group><article-title>Neurologic sequelae after treatment of severe hyponatremia:a multicenter perspective</article-title><source>J Am Soc Nephrol</source><year>1994</year><volume>4</volume><issue>8</issue><fpage>1522</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">8025225</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Dahhan</surname><given-names>J</given-names></name><name><surname>Haycock</surname><given-names>GB</given-names></name><name><surname>Chantler</surname><given-names>C</given-names></name><name><surname>Stimmler</surname><given-names>L</given-names></name></person-group><article-title>Sodium homeostasis in term and preterm neonates. I. Renal aspects</article-title><source>Arch Dis Child</source><year>1983</year><volume>58</volume><issue>5</issue><fpage>335</fpage><lpage>42</lpage><comment>https://doi.org/10.1136/adc.58.5.335 PMid:6&#x02197;12 PMCid:PMC1627895</comment><pub-id pub-id-type="pmid">6859912</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schanler</surname><given-names>RJ</given-names></name><name><surname>Oh</surname><given-names>W</given-names></name></person-group><article-title>Composition of breast milk obtained from mothers of premature infants as compared to breast milk obtained from donors</article-title><source>J Pediatr</source><year>1980</year><volume>96</volume><issue>4</issue><fpage>679</fpage><lpage>81</lpage><comment>https://doi.org/10.1016/S0022-3476(80)80738-4</comment><pub-id pub-id-type="pmid">7359271</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaffer</surname><given-names>SG</given-names></name><name><surname>Bradt</surname><given-names>SK</given-names></name><name><surname>Meade</surname><given-names>VM</given-names></name><name><surname>Hall</surname><given-names>RT</given-names></name></person-group><article-title>Extracellular fluid volume changes in very low birth weight infants during first 2 postnatal months</article-title><source>J Pediatr</source><year>1987</year><volume>111</volume><issue>1</issue><fpage>124</fpage><lpage>8</lpage><comment>https://doi.org/10.1016/S0022-3476(87)80358-X</comment><pub-id pub-id-type="pmid">3110387</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcialis</surname><given-names>MA</given-names></name><name><surname>Dessi</surname><given-names>A</given-names></name><name><surname>Pintus</surname><given-names>MC</given-names></name><name><surname>Marinelli</surname><given-names>V</given-names></name><name><surname>Fanos</surname><given-names>V</given-names></name></person-group><article-title>Hyponatremia and hypernatremia in the newborn:in medio stat virtus</article-title><source>Front Biosci (Elite Ed)</source><year>2012</year><volume>4</volume><fpage>132</fpage><lpage>40</lpage><comment>https://doi.org/10.2741/e364</comment><pub-id pub-id-type="pmid">22201859</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>JM</given-names></name></person-group><article-title>Assessing fluid and electrolyte status in the newborn. National Academy of Clinical Biochemistry</article-title><source>Clin Chem</source><year>1997</year><volume>43</volume><issue>1</issue><fpage>205</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">8990254</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedin</surname><given-names>G</given-names></name><name><surname>Agren</surname><given-names>J</given-names></name></person-group><article-title>Water and heat--the priority for the newborn infant</article-title><source>Ups J Med Sci</source><year>2006</year><volume>111</volume><issue>1</issue><fpage>45</fpage><lpage>59</lpage><comment>https://doi.org/10.3109/2000-1967-027 PMid:16553245</comment><pub-id pub-id-type="pmid">16553245</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wada</surname><given-names>M</given-names></name><name><surname>Kusuda</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Nishida</surname><given-names>H</given-names></name></person-group><article-title>Fluid and electrolyte balance in extremely preterm infants &#x0003c;24 weeks of gestation in the first week of life</article-title><source>Pediatr Int</source><year>2008</year><volume>50</volume><issue>3</issue><fpage>331</fpage><lpage>6</lpage><comment>https://doi.org/10.1111/j.1442-200X.2008.02577.x PMid:18533947</comment><pub-id pub-id-type="pmid">18533947</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>JM</given-names></name></person-group><article-title>Fluid and electrolyte therapy and chronic lung disease</article-title><source>Curr Opin Pediatr</source><year>2004</year><volume>16</volume><issue>2</issue><fpage>152</fpage><lpage>6</lpage><comment>https://doi.org/10.1097/00008480-200404000-00006 PMid:15021193</comment><pub-id pub-id-type="pmid">15021193</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moritz</surname><given-names>ML</given-names></name><name><surname>Ayus</surname><given-names>JC</given-names></name></person-group><article-title>Disorders of water metabolism in children:hyponatremia and hypernatremia</article-title><source>Pediatr Rev</source><year>2002</year><volume>23</volume><issue>11</issue><fpage>371</fpage><lpage>80</lpage><comment>https://doi.org/10.1542/pir.23-11-371</comment><pub-id pub-id-type="pmid">12415016</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baraton</surname><given-names>L</given-names></name><name><surname>Ancel</surname><given-names>PY</given-names></name><name><surname>Flamant</surname><given-names>C</given-names></name><name><surname>Orsonneau</surname><given-names>JL</given-names></name><name><surname>Darmaun</surname><given-names>D</given-names></name><name><surname>Roze</surname><given-names>JC</given-names></name></person-group><article-title>Impact of changes in serum sodium levels on 2-year neurologic outcomes for very preterm neonates</article-title><source>Pediatrics</source><year>2009</year><volume>124</volume><issue>4</issue><fpage>e655</fpage><lpage>61</lpage><comment>https://doi.org/10.1542/peds.2008-3415 PMid:19752079</comment><pub-id pub-id-type="pmid">19752079</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Dahhan</surname><given-names>J</given-names></name><name><surname>Jannoun</surname><given-names>L</given-names></name><name><surname>Haycock</surname><given-names>GB</given-names></name></person-group><article-title>Effect of salt supplementation of newborn premature infants on neurodevelopmental outcome at 10-13 years of age</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>2002</year><volume>86</volume><issue>2</issue><fpage>F120</fpage><lpage>3</lpage><comment>https://doi.org/10.1136/fn.86.2.F120 PMid:11882555 PMCid:PMC1721384</comment><pub-id pub-id-type="pmid">11882555</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gawlowski</surname><given-names>Z</given-names></name><name><surname>Aladangady</surname><given-names>N</given-names></name><name><surname>Coen</surname><given-names>PG</given-names></name></person-group><article-title>Hypernatraemia in preterm infants born at less than 27 weeks gestation</article-title><source>J Paediatr Child Health</source><year>2006</year><volume>42</volume><issue>12</issue><fpage>771</fpage><lpage>4</lpage><comment>https://doi.org/10.1111/j.1440-1754.2006.00975.x PMid:17096711</comment><pub-id pub-id-type="pmid">17096711</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haycock</surname><given-names>GB</given-names></name><name><surname>Aperia</surname><given-names>A</given-names></name></person-group><article-title>Salt and the newborn kidney</article-title><source>Pediatr Nephrol</source><year>1991</year><volume>5</volume><issue>1</issue><fpage>65</fpage><lpage>70</lpage><comment>https://doi.org/10.1007/BF00852850 PMid:2025543</comment><pub-id pub-id-type="pmid">2025543</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rees</surname><given-names>L</given-names></name><name><surname>Brook</surname><given-names>CG</given-names></name><name><surname>Shaw</surname><given-names>JC</given-names></name><name><surname>Forsling</surname><given-names>ML</given-names></name></person-group><article-title>Hyponatraemia in the first week of life in preterm infants. Part I. Arginine vasopressin secretion</article-title><source>Arch Dis Child</source><year>1984</year><volume>59</volume><issue>5</issue><fpage>414</fpage><lpage>22</lpage><comment>https://doi.org/10.1136/adc.59.5.414 PMid:6732271 PMCid:PMC1628500</comment><pub-id pub-id-type="pmid">6732271</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moritz</surname><given-names>ML</given-names></name><name><surname>Ayus</surname><given-names>JC</given-names></name></person-group><article-title>Hyponatremia in preterm neonates:not a benign condition</article-title><source>Pediatrics</source><year>2009</year><volume>124</volume><issue>5</issue><fpage>e1014</fpage><lpage>6</lpage><comment>https://doi.org/10.1542/peds.2009-1869 PMid:19858147</comment><pub-id pub-id-type="pmid">19858147</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>DJ</given-names></name><name><surname>Hope</surname><given-names>PL</given-names></name><name><surname>Johnson</surname><given-names>A</given-names></name></person-group><article-title>Neonatal risk factors for cerebral palsy in very preterm babies:case-control study</article-title><source>BMJ</source><year>1997</year><volume>314</volume><issue>7078</issue><fpage>404</fpage><lpage>8</lpage><comment>https://doi.org/10.1136/bmj.314.7078.404 PMid:9040385 PMCid:PMC2125924</comment><pub-id pub-id-type="pmid">9040385</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovacs</surname><given-names>L</given-names></name><name><surname>Sulyok</surname><given-names>E</given-names></name><name><surname>Lichardus</surname><given-names>B</given-names></name><name><surname>Mihajlovskij</surname><given-names>N</given-names></name><name><surname>Bircak</surname><given-names>J</given-names></name></person-group><article-title>Renal response to arginine vasopressin in premature infants with late hyponatraemia</article-title><source>Arch Dis Child</source><year>1986</year><volume>61</volume><issue>10</issue><fpage>1030</fpage><lpage>2</lpage><comment>https://doi.org/10.1136/adc.61.10.1030 PMid:3777985 PMCid:PMC1777972</comment><pub-id pub-id-type="pmid">3777985</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichardus</surname><given-names>B</given-names></name><name><surname>Sulyok</surname><given-names>E</given-names></name><name><surname>Kovacs</surname><given-names>L</given-names></name><name><surname>Michajlovskij</surname><given-names>N</given-names></name><name><surname>Lehotska</surname><given-names>V</given-names></name><name><surname>Nemethova</surname><given-names>V</given-names></name><name><surname>Varga</surname><given-names>L</given-names></name><name><surname>Ertl</surname><given-names>T</given-names></name></person-group><article-title>Renal salt-wasting increases vasopressin excretion in preterm infants</article-title><source>Monogr Neural Sci</source><year>1986</year><volume>12</volume><fpage>179</fpage><lpage>84</lpage><comment>https://doi.org/10.1159/000412749 PMid:3796644</comment><pub-id pub-id-type="pmid">3796644</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulyok</surname><given-names>E</given-names></name><name><surname>Kovacs</surname><given-names>L</given-names></name><name><surname>Lichardus</surname><given-names>B</given-names></name><name><surname>Michajlovskij</surname><given-names>N</given-names></name><name><surname>Lehotska</surname><given-names>V</given-names></name><name><surname>Nemethova</surname><given-names>V</given-names></name><name><surname>Varga</surname><given-names>L</given-names></name><name><surname>Ertl</surname><given-names>T</given-names></name></person-group><article-title>Late hyponatremia in premature infants:role of aldosterone and arginine vasopressin</article-title><source>J Pediatr</source><year>1985</year><volume>106</volume><issue>6</issue><fpage>990</fpage><lpage>4</lpage><comment>https://doi.org/10.1016/S0022-3476(85)80256-0</comment><pub-id pub-id-type="pmid">3998955</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hazinski</surname><given-names>TA</given-names></name><name><surname>Blalock</surname><given-names>WA</given-names></name><name><surname>Engelhardt</surname><given-names>B</given-names></name></person-group><article-title>Control of water balance in infants with bronchopulmonary dysplasia:role of endogenous vasopressin</article-title><source>Pediatr Res</source><year>1988</year><volume>23</volume><issue>1</issue><fpage>86</fpage><lpage>8</lpage><comment>https://doi.org/10.1203/00006450-198801000-00019 PMid:3340451</comment><pub-id pub-id-type="pmid">3340451</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojima</surname><given-names>T</given-names></name><name><surname>Fukuda</surname><given-names>Y</given-names></name><name><surname>Hirata</surname><given-names>Y</given-names></name><name><surname>Matsuzaki</surname><given-names>S</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name></person-group><article-title>Changes in vasopressin, atrial natriuretic factor, and water homeostasis in the early stage of bronchopulmonary dysplasia</article-title><source>Pediatr Res</source><year>1990</year><volume>27</volume><issue>3</issue><fpage>260</fpage><lpage>3</lpage><comment>https://doi.org/10.1203/00006450-199003000-00011 PMid:213&#x02217;</comment><pub-id pub-id-type="pmid">2138727</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Dahhan</surname><given-names>J</given-names></name><name><surname>Haycock</surname><given-names>GB</given-names></name><name><surname>Nichol</surname><given-names>B</given-names></name><name><surname>Chantler</surname><given-names>C</given-names></name><name><surname>Stimmler</surname><given-names>L</given-names></name></person-group><article-title>Sodium homeostasis in term and preterm neonates. III. Effect of salt supplementation</article-title><source>Arch Dis Child</source><year>1984</year><volume>59</volume><issue>10</issue><fpage>945</fpage><lpage>50</lpage><comment>https://doi.org/10.1136/adc.59.10.945 PMid:6497431 PMCid:PMC1628874</comment><pub-id pub-id-type="pmid">6497431</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haycock</surname><given-names>GB</given-names></name></person-group><article-title>The influence of sodium on growth in infancy</article-title><source>Pediatr Nephrol</source><year>1993</year><volume>7</volume><issue>6</issue><fpage>871</fpage><lpage>5</lpage><comment>https://doi.org/10.1007/BF01213376 PMid:8130123</comment><pub-id pub-id-type="pmid">8130123</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modi</surname><given-names>N</given-names></name></person-group><article-title>Management of fluid balance in the very immature neonate</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>2004</year><volume>89</volume><issue>2</issue><fpage>F108</fpage><lpage>11</lpage><comment>https://doi.org/10.1136/adc.2001.004275 PMid:14977891 PMCid:PMC1756027</comment><pub-id pub-id-type="pmid">14977891</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartnoll</surname><given-names>G</given-names></name><name><surname>Betremieux</surname><given-names>P</given-names></name><name><surname>and</surname><given-names>Modi N</given-names></name></person-group><article-title>Randomised controlled trial of postnatal sodium supplementation on oxygen dependency and body weight in 25-30 week gestational age infants</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>2000</year><volume>82</volume><issue>1</issue><fpage>F19</fpage><lpage>23</lpage><comment>https://doi.org/10.1136/fn.82.1.F19 PMid:10634836 PMCid:PMC1721032</comment><pub-id pub-id-type="pmid">10634836</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modi</surname><given-names>N</given-names></name></person-group><article-title>Sodium intake and preterm babies</article-title><source>Arch Dis Child</source><year>1993</year><volume>69</volume><issue>1 Spec No</issue><fpage>87</fpage><lpage>91</lpage><comment>https://doi.org/10.1136/adc.69.1_Spec_ No.87 PMid:8346966 PMCid:PMC1029411</comment><pub-id pub-id-type="pmid">8346966</pub-id></element-citation></ref></ref-list></back></article>